{"id":"https://openalex.org/W2137329488","doi":"https://doi.org/10.1161/atvbaha.110.204453","title":"Vasoprotective and Atheroprotective Effects of Angiotensin (1-7) in Apolipoprotein E\u2013Deficient Mice","display_name":"Vasoprotective and Atheroprotective Effects of Angiotensin (1-7) in Apolipoprotein E\u2013Deficient Mice","alternate_titles":[],"publication_year":2010,"publication_date":"2010-05-07","ids":{"openalex":"https://openalex.org/W2137329488","doi":"https://doi.org/10.1161/atvbaha.110.204453","mag":"2137329488","pmid":"https://pubmed.ncbi.nlm.nih.gov/20448208"},"language":"en","primary_location":{"id":"doi:10.1161/atvbaha.110.204453","doi":"https://doi.org/10.1161/atvbaha.110.204453","is_oa":false,"landing_page_url":"https://doi.org/10.1161/atvbaha.110.204453","pdf_url":null,"source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, Thrombosis, and Vascular Biology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2137329488"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049528040","display_name":"Sonja Tesanovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sonja Tesanovic","raw_affiliation_strings":["From the Department of Pharmacology, Monash University, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Pharmacology, Monash University, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062825018","display_name":"Antony Vinh","orcid":"https://orcid.org/0000-0001-8367-6134","observed_orcids":["https://orcid.org/0000-0001-8367-6134"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antony Vinh","raw_affiliation_strings":["From the Department of Pharmacology, Monash University, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Pharmacology, Monash University, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010359995","display_name":"Tracey A. Gaspari","orcid":"https://orcid.org/0000-0001-5185-6843","observed_orcids":["https://orcid.org/0000-0001-5185-6843"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tracey A. Gaspari","raw_affiliation_strings":["From the Department of Pharmacology, Monash University, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Pharmacology, Monash University, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109080312","display_name":"David J. CASLEY","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Casley","raw_affiliation_strings":["From the Department of Pharmacology, Monash University, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Pharmacology, Monash University, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070440854","display_name":"Robert E. Widdop","orcid":"https://orcid.org/0000-0002-6515-0435","observed_orcids":["https://orcid.org/0000-0002-6515-0435"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert E. Widdop","raw_affiliation_strings":["From the Department of Pharmacology, Monash University, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Pharmacology, Monash University, Victoria, Australia","institution_ids":["https://openalex.org/I56590836"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5070440854"],"corresponding_institution_ids":["https://openalex.org/I56590836"],"apc_list":null,"apc_paid":null,"fwci":11.2279,"has_fulltext":false,"cited_by_count":162,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9882764,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"30","issue":"8","first_page":"1606","last_page":"1613"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.05869999900460243,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.010700000450015068,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-1-7","display_name":"angiotensin-(1-7)","score":0.9900000095367432},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9670000076293945},{"id":"https://openalex.org/keywords/apoe-deficient-mice","display_name":"ApoE-deficient mice","score":0.9710000157356262},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.9319999814033508},{"id":"https://openalex.org/keywords/nitric-oxide-bioavailability","display_name":"nitric oxide bioavailability","score":0.7829999923706055},{"id":"https://openalex.org/keywords/angiotensin-ii-type-2-receptor","display_name":"angiotensin II type 2 receptor","score":0.8659999966621399},{"id":"https://openalex.org/keywords/mas-receptor","display_name":"Mas receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/superoxide-production","display_name":"superoxide production","score":0.8140000104904175},{"id":"https://openalex.org/keywords/endothelial-nitric-oxide-synthase","display_name":"endothelial nitric oxide synthase","score":0.8640000224113464},{"id":"https://openalex.org/keywords/high-fat-diet","display_name":"high-fat diet","score":0.7919999957084656},{"id":"https://openalex.org/keywords/atherosclerotic-lesion-development","display_name":"atherosclerotic lesion development","score":0.6740000247955322},{"id":"https://openalex.org/keywords/vascular-protection","display_name":"vascular protection","score":0.9409999847412109}],"concepts":[{"id":"https://openalex.org/C2780189551","wikidata":"https://www.wikidata.org/wiki/Q4065146","display_name":"Vasoprotective","level":3,"score":0.7540311217308044},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6980844736099243},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.6800276041030884},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.6502269506454468},{"id":"https://openalex.org/C57089818","wikidata":"https://www.wikidata.org/wiki/Q424728","display_name":"Apolipoprotein E","level":3,"score":0.645106315612793},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.637600839138031},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.5748521089553833},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5676878094673157},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.5561851263046265},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.5487788319587708},{"id":"https://openalex.org/C2776992346","wikidata":"https://www.wikidata.org/wiki/Q111140","display_name":"Endothelium","level":2,"score":0.4753013551235199},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43445685505867004},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4238636791706085},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40427982807159424},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33514297008514404},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.12704741954803467},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09315016865730286},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06894350051879883}],"mesh":[{"descriptor_ui":"D000090063","descriptor_name":"Proto-Oncogene Mas","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000109","descriptor_name":"Acetylcholine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000803","descriptor_name":"Angiotensin I","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001018","descriptor_name":"Aortic Diseases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001018","descriptor_name":"Aortic Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001018","descriptor_name":"Aortic Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001018","descriptor_name":"Aortic Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D001018","descriptor_name":"Aortic Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D001057","descriptor_name":"Apolipoproteins E","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":true},{"descriptor_ui":"D001057","descriptor_name":"Apolipoproteins E","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009569","descriptor_name":"Nitric Oxide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013481","descriptor_name":"Superoxides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014664","descriptor_name":"Vasodilation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044139","descriptor_name":"Receptor, Angiotensin, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052250","descriptor_name":"Nitric Oxide Synthase Type III","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D057912","descriptor_name":"Angiotensin II Type 2 Receptor Blockers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1161/atvbaha.110.204453","doi":"https://doi.org/10.1161/atvbaha.110.204453","is_oa":false,"landing_page_url":"https://doi.org/10.1161/atvbaha.110.204453","pdf_url":null,"source":{"id":"https://openalex.org/S3485792","display_name":"Arteriosclerosis Thrombosis and Vascular Biology","issn_l":"1079-5642","issn":["1079-5642","1524-4636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, Thrombosis, and Vascular Biology","raw_type":"journal-article"},{"id":"pmid:20448208","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20448208","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arteriosclerosis, thrombosis, and vascular biology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320320971","display_name":"Monash University","ror":"https://ror.org/02bfwt286"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"},{"id":"https://openalex.org/F4320334737","display_name":"National Medical Research Council","ror":"https://ror.org/04x3cxs03"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W1909552007","https://openalex.org/W1962884800","https://openalex.org/W1965599418","https://openalex.org/W1972471019","https://openalex.org/W1972642912","https://openalex.org/W1973472396","https://openalex.org/W1974765210","https://openalex.org/W1979582673","https://openalex.org/W1987430295","https://openalex.org/W2000040025","https://openalex.org/W2004840558","https://openalex.org/W2014363167","https://openalex.org/W2034963012","https://openalex.org/W2042368828","https://openalex.org/W2043908786","https://openalex.org/W2053328405","https://openalex.org/W2060927358","https://openalex.org/W2066500319","https://openalex.org/W2070212734","https://openalex.org/W2072570093","https://openalex.org/W2079577579","https://openalex.org/W2083529118","https://openalex.org/W2095502235","https://openalex.org/W2099825476","https://openalex.org/W2101345537","https://openalex.org/W2103115053","https://openalex.org/W2103521123","https://openalex.org/W2108312009","https://openalex.org/W2112148801","https://openalex.org/W2112662621","https://openalex.org/W2120699999","https://openalex.org/W2121985419","https://openalex.org/W2126651811","https://openalex.org/W2127293529","https://openalex.org/W2127844344","https://openalex.org/W2131170531","https://openalex.org/W2131748151","https://openalex.org/W2137225581","https://openalex.org/W2146081639","https://openalex.org/W2147748270","https://openalex.org/W2150388314","https://openalex.org/W2152362788","https://openalex.org/W2155808437","https://openalex.org/W2156950978","https://openalex.org/W2158044437","https://openalex.org/W2158908362","https://openalex.org/W2159872857","https://openalex.org/W2160071918","https://openalex.org/W2161399617","https://openalex.org/W2161739223","https://openalex.org/W2169328873","https://openalex.org/W2171507037","https://openalex.org/W2321747774","https://openalex.org/W2324841714","https://openalex.org/W2411907844","https://openalex.org/W4256475235"],"related_works":["https://openalex.org/W2784925193","https://openalex.org/W27747010","https://openalex.org/W2478711916","https://openalex.org/W2042322664","https://openalex.org/W1613083159","https://openalex.org/W2998316693","https://openalex.org/W2579037783","https://openalex.org/W3030522681","https://openalex.org/W2602887915","https://openalex.org/W2131170531"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,13,37,209],"effectiveness":[4],"of":[5,15,44,53,59,200,211,220],"long-term":[6,45],"angiotensin":[7,93],"(Ang)":[8],"(1-7)":[9,26,48,82,105,155,179],"treatment":[10,49,83,106,156,180],"to":[11,35,146,205],"inhibit":[12],"progression":[14,196],"atherosclerosis":[16],"in":[17,64,173,186,194,197],"apolipoprotein":[18,65],"E-deficient":[19],"(ApoE(-/-))":[20],"mice.":[21],"METHODS":[22],"AND":[23],"RESULTS:":[24],"Ang":[25,38,47,81,104,154,170,178],"is":[27],"a":[28,192,198,217],"heptapeptide":[29],"fragment":[30],"that":[31,68],"has":[32],"been":[33,70],"proposed":[34],"counterregulate":[36],"II":[39],"proatherogenic":[40],"effects.":[41],"The":[42],"effect":[43,89],"4-week":[46],"on":[50],"both":[51,128,138,182,221],"inhibition":[52],"atherosclerotic":[54],"lesion":[55,174,195],"development":[56],"and":[57,111,130,144,189,215,223],"improvement":[58,185],"endothelial":[60,86,113,187],"function":[61],"was":[62,149],"examined":[63],"E(-/-)":[66],"mice":[67],"had":[69],"fed":[71],"an":[72,88],"atherogenic":[73],"high-fat":[74],"(21%)":[75],"diet":[76],"for":[77],"16":[78],"weeks.":[79],"Chronic":[80],"significantly":[84,107,151],"improved":[85],"function,":[87,188],"reversed":[90,169],"with":[91,120,153,158,162,191],"either":[92,163],"type":[94],"2":[95],"(AT(2))":[96],"or":[97,165],"Mas":[98,131,166,222],"receptor":[99,132,167],"blockade.":[100],"In":[101],"these":[102],"vessels,":[103],"decreased":[108,152],"superoxide":[109],"production":[110],"increased":[112],"nitric":[114,212],"oxide":[115,213],"synthase":[116],"immunoreactivity":[117],"when":[118],"compared":[119,157],"vehicle":[121],"treatment.":[122],"These":[123,202],"effects":[124,203],"were":[125],"blocked":[126],"by":[127,208],"AT(2)":[129,164,224],"antagonists.":[133],"Lesion":[134],"development,":[135],"assessed":[136],"as":[137],"fatty":[139],"deposits":[140],"(oil":[141],"red":[142],"O)":[143],"intima":[145],"media":[147],"ratio,":[148],"also":[150],"respective":[159],"controls.":[160],"Cotreatment":[161],"antagonists":[168],"(1-7)-mediated":[171],"reduction":[172,193],"development.":[175],"CONCLUSIONS:":[176],"Long-term":[177],"caused":[181],"vasoprotection,":[183],"via":[184],"atheroprotection,":[190],"model":[199],"atherosclerosis.":[201],"appear":[204],"be":[206],"mediated":[207],"restoration":[210],"bioavailability":[214],"involve":[216],"complex":[218],"interaction":[219],"receptors.":[225]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2137329488","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":25},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":18},{"year":2012,"cited_by_count":28}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
